StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Rating) in a research report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright upgraded Onconova Therapeutics from a neutral rating to a buy rating and set a $11.00 price objective on the stock in a […]